This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_THYROID_GLAND_EXALLC for full statistics.
Malignant neoplasm of thyroid gland
C3_THYROID_GLAND
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
2581 |
4. Check minimum number of eventsNone |
2581 |
5. Include endpointsNone |
2581 |
6. Filter based on genotype QC (FinnGen only) |
2581 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF9
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of thyroid gland
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of endocrine gland
- Malignant neoplasm of thyroid gland, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of endocrine gland, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm
- Malignant neoplasm, excluding all cancers (controls excluding all cancers)
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 2581 | 1917 | 664 |
| Unadjusted period prevalence (%) | 0.56 | 0.65 | 0.29 |
| Median age at first event (years) | 50.73 | 48.21 | 58.02 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 2400
- Matched controls
- 24011
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
8260/3-C73.9
ICD-O-3
Papillary adenocarcinoma, NOS, of thyroid gland
+∞
323.0
1816
*
104
Kela drug reimbursment
Thyroid insufficiency
78.3
323.0
1807
897
H03AA01
ATC
levothyroxine sodium; systemic
93.6
323.0
2281
4051
C73.90
ICD-10 Finland
Malignant tumor of the thyroid gland (thyroid gland) without histology
2080.0
323.0
342
*
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
10632.3
323.0
1877
8
XX7CT
NOMESCO Finland
Radioiodine therapy of thydoid tissue
276.2
323.0
676
34
C73
ICD-10 Finland
Malignant neoplasm of thyroid gland
+∞
323.0
357
*
ZX114
NOMESCO Finland
Intramuscular
44.9
323.0
418
112
EP1AE
NOMESCO Finland
Neck ultrasound examination
38.2
323.0
1197
608
BAA60
NOMESCO Finland
Total thyroidectomy
152.5
323.0
1350
201
JN5PN
NOMESCO Finland
Isotope imaging of secondary neoplasms of thyroid origin
+∞
323.0
620
*
D44.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Thyroid gland
74.5
323.0
650
119
BAA40
NOMESCO Finland
Unilateral lobectomy of thyroid gland
29.1
323.0
544
239
E89.01
ICD-10 Finland
Postsurgical hypothyroidism
74.1
323.0
701
133
JN5AQ
NOMESCO Finland
SPECT of thyroid metastasis with low-dose CT
1790.4
322.1
306
*
C73.99
ICD-10 Finland
Malignant tumor of the thyroid gland (thyroid gland), other or unspecified histology
1690.4
307.9
293
*
4CJ01
NOMESCO Finland
NA
3154.3
306.8
290
*
C73.92
ICD-10 Finland
Follicular carcinoma of the thyroid gland
1600.1
294.8
281
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
4.7
270.9
1415
5603
BA3AT
NOMESCO Finland
Cytology of thyroid with ultrasound quidance
25.9
237.4
338
151
1930A
ICD-9 Finland
Malignant neoplasm of thyroid gland[CARCINOMA PAPILLARE THYREOIDEAE]
+∞
221.3
209
*
BA1NN
NOMESCO Finland
I-131 dose capsel measurement
+∞
213.8
202
*
8330/3-C73.9
ICD-O-3
Follicular carcinoma, NOS, of thyroid gland
+∞
206.3
195
*
J38.0
ICD-10 Finland
Paralysis of vocal cords and larynx
23.6
192.3
281
134
E04.2
ICD-10 Finland
Nontoxic multinodular goitre
9.5
170.0
372
455
T71
ICPC
Malignant neoplasm thyroid
+∞
164.5
156
*
PJD71
NOMESCO Finland
Extended sparing excision of cervical lymph nodes
66.4
164.3
190
31
E89.2
ICD-10 Finland
Postprocedural hypoparathyroidism
64.4
144.6
168
28
2506
FHL
Thyroidectomy
161.0
144.1
151
10
19399
ICD-8 Finland
Malignant neoplasm of thyroid gland
+∞
136.8
130
*
106
Kela drug reimbursment
Hypoparathyroidism
105.9
136.8
149
15
A11CC03
ATC
alfacalcidol; systemic
13.0
130.1
238
201
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
21.1
120.7
182
93
8341/3-C73.9
ICD-O-3
Papillary microcarcinoma of thyroid gland
+∞
119.8
114
*
Z51.88
ICD-10 Finland
Other specified medical care
14.4
114.6
200
151
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
19.7
107.8
166
90
E04.1
ICD-10 Finland
Nontoxic single thyroid nodule
12.6
100.1
185
158
WX408
NOMESCO Finland
General anesthesy, balanced
2.7
98.9
887
4228
E89.09
ICD-10 Finland
Postprocedural hypothyroidism, other or several procedures
65.8
97.7
113
18
C739
ICD-10 Finland
NA
976.5
96.7
94
*
E04.9
ICD-10 Finland
Nontoxic goitre, unspecified
9.9
94.4
197
214
8340/3-C73.9
ICD-O-3
Papillary carcinoma, follicular variant of thyroid gland
+∞
93.3
89
*
BA1AE
NOMESCO Finland
Thyroiid ultrasound examination
11.3
88.4
172
163
PJD81
NOMESCO Finland
Excision of lymph nodes from upper part of neck
39.1
88.1
112
30
ZXE10
NOMESCO Finland
More than one and less than three hours
2.4
84.4
1077
6095
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.6
78.7
702
3247
D34
ICD-10 Finland
Benign neoplasm of thyroid gland
18.8
78.3
122
68
EP1DG
NOMESCO Finland
Very extensive examination of soft tissue of neck with high intesity magnet
27.2
73.6
102
39
A11CC02
ATC
dihydrotachysterol; oral
52.4
71.8
86
17
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
16.8
70.3
114
71
WX402
NOMESCO Finland
General anaesthesia
2.6
65.3
554
2448
E83.51
ICD-10 Finland
Hypocalcemia
25.5
64.6
91
37
R22.1
ICD-10 Finland
Localized swelling, mass and lump, neck
5.4
61.4
194
382
UDQ12
NOMESCO Finland
Flexible laryngoscopy
4.1
56.9
236
616
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.1
56.3
928
5590
A12AA04
ATC
calcium carbonate; oral
10.4
55.4
111
111
C73.94
ICD-10 Finland
Medullary thyroid carcinoma (thyroid)
550.2
54.8
54
*
JN5SN
NOMESCO Finland
NA
+∞
54.4
52
*
EP2AT
NOMESCO Finland
Neck soft tissue cytology with ultrasound guidance
54.7
54.0
64
12
WB223
NOMESCO Finland
Demanding adjuvant hormone therapy of malignancy
40.5
53.4
67
17
130
Kela drug reimbursment
Malignant tumour
3.4
52.0
270
851
XW1AT
NOMESCO Finland
Biopsy from other organ close to skin with ultrasound quidance
24.2
51.2
73
31
PJD91
NOMESCO Finland
Excision of lymph nodes in neck, 1 to 2 areas in total
173.6
49.0
51
*
A12AA06
ATC
calcium lactate gluconate; oral
132.8
49.0
52
*
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
24.2
46.4
66
28
ZXE20
NOMESCO Finland
More than three and less than five hours
2.5
45.9
410
1825
2505
FHL
Bilateral resection (also used if total removal has been performed on the other side)
13.2
43.4
77
60
ZXD10
NOMESCO Finland
Scheduled procedure
1.8
41.6
1005
6759
WW200
NOMESCO Finland
Immunization
5.3
39.5
126
250
XX9AQ
NOMESCO Finland
Supplementary SPECT-CT or additional scan
47.9
38.9
47
10
C73.93
ICD-10 Finland
Anaplastic thyroid carcinoma (thyroid)
+∞
38.6
37
*
T86
ICPC
Hypothyroidism/myxoedema
3.8
35.6
158
436
GD1AD
NOMESCO Finland
Thorax CT examination
3.8
35.5
157
431
BAA99
NOMESCO Finland
Other operation on thyroid gland
125.2
34.8
37
*
8290/3-C73.9
ICD-O-3
Oxyphilic adenocarcinoma of thyroid gland
+∞
34.5
33
*
ZXA10
NOMESCO Finland
Bilateral
2.0
32.7
498
2788
BA1AQ
NOMESCO Finland
Thyroid SPECT with low dose CT
306.1
29.9
30
*
ZSB00
NOMESCO Finland
Procedure related to previous procedure classified in chapter B
156.9
29.7
31
*
XX6XT
NOMESCO Finland
Other intravascular therapy with radiological guidance
15.8
29.5
48
31
8510/3-C73.9
ICD-O-3
Medullary carcinoma, NOS, of thyroid gland
+∞
28.2
27
*
E03.89
ICD-10 Finland
Other specified hypothyroidism
3.5
27.5
135
405
8345/3-C73.9
ICD-O-3
Medullary thyroid carcinoma of thyroid gland
+∞
27.1
26
*
PJD51
NOMESCO Finland
Block dissection of cervical lymph nodes
62.8
27.0
31
5
WX704
NOMESCO Finland
Intubation
2.5
26.8
217
905
O99.2
ICD-10 Finland
Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium
6.2
26.7
73
121
GD6AD
NOMESCO Finland
CT of chest and neck
22.7
26.5
38
17
E04.0
ICD-10 Finland
Nontoxic diffuse goitre
8.6
26.1
57
68
DQE10
NOMESCO Finland
Injection of foreign material into vocal cord
24.3
25.7
36
15
PJD99
NOMESCO Finland
Excision of other lymph nodes
136.5
25.6
27
*
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
6.2
25.6
70
116
E8901, C7391
ICD-10 Finland
NA
+∞
25.0
24
*
Z01.8
ICD-10 Finland
Other specified special examinations
1.8
24.8
523
3247
XX1MN
NOMESCO Finland
Isotope examination with measurement
252.7
24.7
25
*
TPH07
NOMESCO Finland
Cathetrisation of artery
2.2
24.3
265
1280
N02BE01
ATC
paracetamol; systemic, rectal
1.8
24.1
2046
18327
BBA30
NOMESCO Finland
Excision of lesion of parathyroid gland
6.1
24.1
66
110
ZXA05
NOMESCO Finland
Left side
1.7
23.3
604
3978
Z85.8
ICD-10 Finland
Personal history of malignant neoplasms of other organs and systems
54.6
23.1
27
5
198
Kela drug reimbursment
Sorafenib
30.4
22.8
30
10
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.6
22.1
957
7187
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
5.6
22.1
65
119
WA039
NOMESCO Finland
Radiotherapy with free isotopes
+∞
21.9
21
*
8000/3-C73.9
ICD-O-3
Neoplasm, malignant of thyroid gland
+∞
21.9
21
*
BAA20
NOMESCO Finland
Unilateral partial excision of thyroid gland
14.0
21.3
36
26
2504
FHL
Unilateral resection or enucleation
7.5
21.2
50
68
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
2.7
21.0
148
569
8020/3-C73.9
ICD-O-3
Carcinoma, undifferentiated, NOS, of thyroid gland
+∞
20.9
20
*
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
7.4
20.2
48
66
1930X
ICD-9 Finland
Malignant neoplasm of thyroid gland[NEOPLASMA MALIGNUM THYREOIDEAE EI HISTOL VAHV]
+∞
19.8
19
*
BA2MN
NOMESCO Finland
Thyroid radiation dose measurement during isotope therapy
+∞
19.8
19
*
BA2AT
NOMESCO Finland
Biopsy of thyroid with ultrasound quidance
74.1
19.7
22
*
323
Kela drug reimbursment
Sorafenib
74.1
19.7
22
*
BBA70
NOMESCO Finland
Implantation or transplantation of parathyroid gland
29.2
19.6
26
9
E05.0
ICD-10 Finland
Thyrotoxicosis with diffuse goitre
3.3
19.6
100
310
WZC30
NOMESCO Finland
Teaching
1.9
19.2
322
1836
JN6AD
NOMESCO Finland
CT of torso and neck
6.0
19.2
53
90
ZXA00
NOMESCO Finland
Right side
1.6
19.2
616
4267
E21.09
ICD-10 Finland
Other primary hyperparathyroidism
4.3
18.9
71
170
1930B
ICD-9 Finland
Malignant neoplasm of thyroid gland[CARCINOMA FOLLICULARE THYREOIDEAE]
+∞
18.8
18
*
8010/3-C73.9
ICD-O-3
Carcinoma, NOS, of thyroid gland
+∞
18.8
18
*
ZXE00
NOMESCO Finland
One hour or less
1.5
17.9
902
6909
ZXE30
NOMESCO Finland
More than five and less than seven hours
2.6
17.8
135
541
1508
Kela drug reimbursment
Lenvatinib
95.8
17.6
19
*
3019
Kela drug reimbursment
Lenvatinib
95.8
17.6
19
*
H03BB01
ATC
carbimazole; oral
2.7
17.4
122
467
WF049
NOMESCO Finland
Radiotherapy of metastasis
3.2
17.1
90
287
JN5AN
NOMESCO Finland
Total body isotope imaging
63.8
16.7
19
*
EP1DM
NOMESCO Finland
Very extensive MRI examination of soft tissue of neck with 3 Tesla magnet
63.8
16.7
19
*
1AB01
NOMESCO Finland
NA
+∞
16.7
16
*
E20.8
ICD-10 Finland
Other hypoparathyroidism
35.3
16.7
21
6
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
3.2
16.6
89
287
R49.01
ICD-10 Finland
Functional dysphonia
3.0
16.2
95
327
BWD00
NOMESCO Finland
Reoperation for deep haemorrhage in endocrine surgery
33.6
15.7
20
6
E05.9
ICD-10 Finland
Thyrotoxicosis, unspecified
3.1
15.2
83
272
L01XE05
ATC
[U] sorafenib; oral
28.8
15.2
20
7
GD6BD
NOMESCO Finland
Extensive CT of chest and neck
17.8
15.1
23
13
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
2.7
14.7
99
372
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.7
14.5
297
1801
R13
ICD-10 Finland
Dysphagia
2.2
14.1
150
714
Z50.5
ICD-10 Finland
Speech therapy
4.8
14.1
46
97
JN4BD
NOMESCO Finland
Extensive body CT
1.8
13.9
237
1355
2410A
ICD-9 Finland
Non-toxic nodular goitre, Non-toxic uninodular goitre
12.7
13.9
24
19
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
6.7
13.7
34
51
E03
ICD-10 Finland
Other hypothyroidism
2.1
13.7
155
761
WX725
NOMESCO Finland
Noninvasive ventilation
2.3
13.5
123
544
E20.9
ICD-10 Finland
Hypoparathyroidism, unspecified
21.3
13.3
19
9
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
5.0
13.1
41
83
XX3DW
NOMESCO Finland
Time consuming IT work
1.8
13.0
229
1323
RL210
NOMESCO Finland
NA
10.1
13.0
25
25
WF002
NOMESCO Finland
Radical radiotherapy
2.5
12.9
97
390
R49.08
ICD-10 Finland
Other specified dysphonia
3.1
12.8
70
232
L01XE29
ATC
[U] lenvatinib; oral
130.7
12.4
13
*
24199
ICD-8 Finland
Non-toxic nodular goitre, Unspecified
4.9
12.3
39
80
XX9XW
NOMESCO Finland
NA
6.5
12.3
31
48
PJA10
NOMESCO Finland
Exploration of lymph nodes
4.7
12.3
41
89
BAA30
NOMESCO Finland
Excision of thyroid isthmus
21.4
12.0
17
8
EP1CM
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with 3 Tesla magnet
14.7
11.8
19
13
QX4AT
NOMESCO Finland
Ultrsound guided needle biopsy of skin
8.4
11.8
25
30
WX400
NOMESCO Finland
Inhalation anesthesy
2.3
11.5
105
468
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
5.6
11.3
32
58
R4130
NOMESCO Finland
Speech therapy
3.4
11.2
53
159
EP1AT
NOMESCO Finland
Punction of soft tissue of neck with ultrasound guidance
43.5
10.9
13
*
B01AB05
ATC
enoxaparin; parenteral
1.4
10.8
633
4881
2260A
ICD-9 Finland
Benign neoplasm of thyroid gland[NEOPLASMA BENIGNUM GLANDULAE THYREOIDEAE]
12.0
10.8
19
16
J01DB01
ATC
cefalexin; oral
1.4
10.8
1844
16894
E05.2
ICD-10 Finland
Thyrotoxicosis with toxic multinodular goitre
3.7
10.8
46
127
D11.0
ICD-10 Finland
Benign neoplasm: Parotid gland
3.7
10.8
45
122
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
2.5
10.6
82
337
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
6.0
10.6
28
47
8335/3-C73.9
ICD-O-3
Follicular carcinoma, minimally invasive of thyroid gland
+∞
10.4
10
*
EP1AE
SPAT
NA
3.8
10.4
42
111
2419X
ICD-9 Finland
Non-toxic nodular goitre, Unspecified non-toxic nodular goitre
7.7
10.4
23
30
D25.9
ICD-10 Finland
Leiomyoma of uterus, unspecified
1.7
10.3
212
1285
JN4AD
NOMESCO Finland
Body CT examination
1.9
10.2
155
853
S18
ICPC
Laceration/cut
1.3
10.2
850
6941
UDH02
NOMESCO Finland
Rhinopharyngoscopy
1.9
10.2
141
751
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
3.3
10.1
49
150
TPH04
NOMESCO Finland
Cathetrisation of vein
1.5
10.1
429
3112
UDQ02
NOMESCO Finland
Direct laryngoscopy
5.1
10.0
30
59
ENB50
NOMESCO Finland
Excision of cyst or fistula of thyroglossic duct
16.8
9.9
15
9
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
2.0
9.8
118
596
GAB20
NOMESCO Finland
Median sternotomy
26.1
9.8
13
5
D25.1
ICD-10 Finland
Intramural leiomyoma of uterus
1.9
9.7
143
778
R22.9
ICD-10 Finland
Localized swelling, mass and lump, unspecified
1.8
9.6
152
848
WX720
NOMESCO Finland
Own respiration
2.2
9.5
92
424
E89.00
ICD-10 Finland
Postirradiation hypothyroidism
4.3
9.3
33
78
Z31.5
ICD-10 Finland
Genetic counselling
2.0
9.2
115
590
N02AA05
ATC
oxycodone; systemic
1.6
9.1
263
1747
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
5.0
9.1
28
57
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
1.8
9.1
162
940
4701
FHL
Neck lymph node removal
11.5
9.1
16
14
UGB02
NOMESCO Finland
Tracheoscopy
15.6
9.0
14
9
2397A
ICD-9 Finland
Neoplasm of unspecified nature, Endocrine glands and other parts of nervous system
18.7
8.9
13
7
E21.0
ICD-10 Finland
Primary hyperparathyroidism
3.3
8.9
42
127
BAA50
NOMESCO Finland
Lobectomy and resection of contralateral lobe of thyroid gland
12.6
8.9
15
12
WF004
NOMESCO Finland
Palliative radiotherapy
3.2
8.8
44
139
2509
FHL
Other measure in this category
50.2
8.7
10
*
DQE20
NOMESCO Finland
Implantation of foreign material in vocal chord
50.2
8.7
10
*
E89.0
ICD-10 Finland
Postprocedural hypothyroidism
11.6
8.6
15
13
E83.50
ICD-10 Finland
Hypercalcemia
3.9
8.4
33
86
2502
FHL
Thyroid exploration and possible biopsy
90.4
8.4
9
*
D09.3
ICD-10 Finland
Carcinoma in situ: Thyroid and other endocrine glands
90.4
8.4
9
*
T85
ICPC
Hyperthyroidism/thyrotoxicosis
4.9
8.4
26
54
C75
ICD-10 Finland
Malignant neoplasm of other endocrine glands and related structures
+∞
8.3
8
*
SPAT1153
SPAT
Removal of sutures
1.3
8.3
642
5147
GBB00
NOMESCO Finland
Tracheostomy
4.3
8.3
29
68
Z3226
NOMESCO Finland
Physiotherapist
1.4
8.3
373
2730
BB1BQ
NOMESCO Finland
Extensive scintigraphy of parathyroid gland, 2 isotopes, SPECT and low-dose CT
7.1
8.2
19
27
ZX070
NOMESCO Finland
Intensity modified radiotherapy
3.0
8.2
45
153
E21.3
ICD-10 Finland
Hyperparathyroidism, unspecified
3.7
8.1
34
94
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
4.0
7.9
30
76
R49.8
ICD-10 Finland
Other and unspecified voice disturbances
3.5
7.9
34
97
S04
ICPC
Lump/swelling localized
1.6
7.8
182
1143
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
1.7
7.8
159
962
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.5
7.8
311
2218
UDC00
NOMESCO Finland
Ear microscopy
1.7
7.7
141
827
A03FA01
ATC
metoclopramide; systemic, rectal
1.4
7.7
438
3340
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
2.6
7.6
51
196
R21
ICPC
Throat symptom/complaint
1.4
7.6
381
2842
L01EX08
ATC
lenvatinib; oral
80.3
7.4
8
*
D44.8
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Pluriglandular involvement
80.3
7.4
8
*
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
1.8
7.4
129
746
EP1BG
NOMESCO Finland
MRI examination of soft tissue of neck with high intesity magnet
6.0
7.4
19
32
R49.09
ICD-10 Finland
Unspecified dysphonia
3.7
7.3
30
82
HA1AA
NOMESCO Finland
X-ray mammography
1.6
7.3
177
1125
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.3
7.3
822
6925
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
2.0
7.3
86
434
2374A
ICD-9 Finland
Neoplasm of uncertain behaviour of endocrine glands and nervous system, Other and unspecified endocrine glands
+∞
7.3
7
*
9680/3-C73.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of thyroid gland
+∞
7.3
7
*
WX734
NOMESCO Finland
JET-ventilation
15.8
7.2
11
7
UJC01
NOMESCO Finland
Scopy of lower throat
4.1
7.2
26
64
R07.0
ICD-10 Finland
Pain in throat
1.8
7.1
121
694
D44.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Adrenal gland
3.7
7.1
29
80
H02AB02
ATC
dexamethasone; systemic
1.5
7.0
213
1432
J37.0
ICD-10 Finland
Chronic laryngitis
2.1
6.9
71
340
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
1.8
6.8
106
592
H02AB09
ATC
hydrocortisone; systemic
2.6
6.8
48
190
2411A
ICD-9 Finland
Non-toxic nodular goitre, Non-toxic multinodular goitre
5.3
6.8
19
36
M01AE01
ATC
ibuprofen; systemic, rectal
1.4
6.8
2046
19432
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
3.9
6.8
26
68
C74.9
ICD-10 Finland
Malignant neoplasm: Adrenal gland, unspecified
40.2
6.8
8
*
E20
ICD-10 Finland
Hypoparathyroidism
40.2
6.8
8
*
T73
ICPC
Neoplasm endocrine other/unspecified
16.7
6.7
10
6
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
4.7
6.7
21
45
E07.9
ICD-10 Finland
Disorder of thyroid, unspecified
6.9
6.5
15
22
D25.0
ICD-10 Finland
Submucous leiomyoma of uterus
1.9
6.5
84
442
M01AE03
ATC
ketoprofen; systemic, rectal
1.3
6.4
763
6452
Q18.0
ICD-10 Finland
Sinus, fistula and cyst of branchial cleft
6.0
6.3
16
27
1930D
ICD-9 Finland
Malignant neoplasm of thyroid gland[CARCINOMA MEDULLARE THYREOIDEAE]
+∞
6.3
6
*
C73, C75
ICD-10 Finland
NA
+∞
6.3
6
*
DQB60
NOMESCO Finland
Aryotenoidectomy
+∞
6.3
6
*
9591/3-C73.9
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of thyroid gland
+∞
6.3
6
*
ZXB10
NOMESCO Finland
Medial
5.3
6.1
17
32
WX110
NOMESCO Finland
Local anesthesy
1.2
6.1
1472
13462
A02BC05
ATC
esomeprazole; systemic
1.3
6.1
842
7239
R59.9
ICD-10 Finland
Enlarged lymph nodes, unspecified
3.7
6.1
24
65
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
582
572
12.85
307.65
1.5
1.2
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
1823
116
533.21
307.65
8.1
1.8
u/ml
56.7
174.3
0.98
692
30
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
1850
30
2176.92
307.65
7.8
3.2
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
1573
1409
27.04
307.65
7.5
3.0
pmol/l
4.5
4.5
0.10
1526
1237
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
2041
10727
5.32
291.20
12.3
6.5
mmol/l
1.2
1.2
33.65
1719
9066
(3018418) pH of Serum or Plasma
1503
6404
4.23
284.56
8.6
3.9
ph
7.4
7.4
1.25
329
1200
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
688
1672
5.25
273.27
3.2
3.5
ng/l
48.9
83.2
35.91
616
1440
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
1880
9720
4.44
262.35
10.1
5.8
mmol/l
1.2
1.2
24.68
1799
8804
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
2445
17459
8.65
179.81
11.7
4.2
pmol/l
17.9
14.7
307.65
2378
15986
(3015377) Calcium [Moles/volume] in Serum or Plasma
1361
7536
2.71
132.42
4.1
3.4
mmol/l
2.3
2.4
47.45
1240
6623
(4035726)
550
1988
3.25
116.99
1.5
1.4
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
1512
9403
2.47
106.90
2.9
2.3
nmol/l
79.2
78.2
0.83
1427
8474
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
2457
20408
5.28
85.83
15.4
4.9
mu/l
1.7
2.1
1.11
2364
18790
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
192
412
4.95
84.32
2.5
2.7
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
652
3398
2.23
62.07
3.6
3.3
mmol/l
0.8
0.8
0.21
622
3178
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
410
1761
2.58
60.29
7.6
3.5
mmol/l
1.2
1.2
14.14
382
1522
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
1435
10233
1.91
54.72
4.1
4.0
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
1065
6909
1.92
54.14
2.3
2.3
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
1314
9293
1.84
49.51
2.4
2.1
—
—
—
0
0
(3002256) Pathology report gross observation
544
2866
2.14
49.02
1.4
1.3
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
2047
16821
2.05
46.84
9.5
7.5
u/l
75.3
77.5
2.21
1977
15842
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
689
4027
1.97
46.35
3.6
3.0
mmol/l
2.4
2.5
21.30
619
3544
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
167
519
3.37
43.81
2.3
1.7
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
1287
9281
1.77
43.29
5.1
4.7
g/l
36.3
35.7
4.46
1219
8645
(3003458) Phosphate [Moles/volume] in Serum or Plasma
475
2705
1.93
33.17
5.5
5.6
mmol/l
1.1
1.0
3.02
440
2509
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
769
5268
1.65
27.83
2.2
2.3
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
1542
12471
1.59
27.67
5.0
4.7
mmol/l
6.5
6.6
1.21
1461
11657
(3010838) Calcium [Moles/time] in 24 hour Urine
59
126
4.77
25.97
1.9
1.8
mmol/24h
3.8
9.5
—
5
9
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
1407
11278
1.54
25.16
7.1
6.2
umol/l
11.1
10.9
0.24
1348
10696
(3013650) Neutrophils [#/volume] in Blood by Automated count
1546
12673
1.55
24.80
9.2
9.1
e9/l
3.9
4.0
2.01
1362
11098
(3019550) Sodium [Moles/volume] in Serum or Plasma
2409
22382
2.15
21.16
18.1
15.4
mmol/l
139.8
139.7
2.32
2373
21833
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
143
605
2.44
21.11
1.7
1.9
iu/l
4.3
4.7
0.20
65
209
(3012565) Volume of 24 hour Urine
47
102
4.67
20.33
3.0
2.3
ml
1820.5
1911.0
0.26
42
87
(3023103) Potassium [Moles/volume] in Serum or Plasma
2410
22450
2.12
20.12
18.4
15.5
mmol/l
3.9
4.0
16.80
2364
21862
(3032080) INR in Blood by Coagulation assay
1041
8243
1.44
17.28
8.3
8.6
inr
1.2
1.2
0.70
330
2404
(3033658) Prothrombin time (PT) actual/Normal
737
5469
1.49
17.13
3.8
3.7
%
94.2
92.8
0.92
723
5324
(3044889) 12 lead EKG panel
1756
15313
1.46
17.08
4.1
3.6
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
2342
21843
1.78
16.02
17.3
13.6
mg/l
19.3
22.3
5.46
1947
17216
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
341
2153
1.67
15.97
3.4
3.3
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
2022
18225
1.51
15.83
21.5
16.5
%
13.5
13.7
4.68
2002
17831
(3047181) Lactate [Moles/volume] in Blood
133
648
2.11
14.08
5.1
7.6
mmol/l
1.2
1.2
0.12
118
564
(3020564) Creatinine [Moles/volume] in Serum or Plasma
2440
23174
1.97
13.95
21.3
15.7
umol/l
74.4
73.7
0.52
2440
23169
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
78
305
2.61
13.66
1.9
1.3
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
2405
22760
1.84
13.55
17.5
12.8
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
81
327
2.52
13.29
1.9
1.3
nmol/l
0.1
0.4
—
6
20
(3013707) Erythrocyte sedimentation rate by Westergren method
1828
16398
1.39
12.70
4.4
4.1
mm/h
12.1
12.1
0.02
1702
15223
(3039000) Anion gap in Blood
100
455
2.25
12.59
5.4
9.2
mmol/l
11.1
11.1
0.04
92
411
(3018572) Chloride [Moles/volume] in Blood
100
456
2.24
12.52
5.4
9.2
mmol/l
106.0
105.1
1.76
92
412
(3036481) Cortisol [Moles/volume] in Serum or Plasma
318
2106
1.58
12.14
2.6
2.1
nmol/l
387.9
368.8
0.51
297
1920
(3019225) pH of Specimen
326
2195
1.56
11.56
9.3
4.0
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
185
1077
1.77
11.56
8.0
11.4
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
898
7312
1.35
11.23
5.9
5.9
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
69
288
2.43
10.62
1.9
1.3
nmol/l
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
324
2220
1.53
10.58
4.3
4.1
ug/l
23.4
24.8
0.03
245
1790
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
334
2306
1.52
10.52
6.9
8.0
kpa
5.1
5.1
0.25
316
2212
(3027801) Oxygen [Partial pressure] in Arterial blood
334
2307
1.51
10.50
6.8
8.0
kpa
12.6
12.5
0.09
316
2212
(3003396) Base excess in Arterial blood by calculation
333
2299
1.51
10.49
6.9
8.0
mmol/l
1.3
1.2
0.28
268
1806
(3016502) Oxygen saturation in Arterial blood
301
2040
1.54
10.33
7.0
8.6
%
95.9
95.7
0.11
289
1974
(3003694) ABO and Rh group [Type] in Blood
733
5858
1.35
10.15
1.4
1.4
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
1289
11183
1.31
9.91
5.9
5.9
e9/l
1.9
1.9
0.07
1136
9896
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
2203
20696
1.44
9.57
16.9
12.5
ml/min/173m2
83.7
81.6
5.15
1945
17077
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
49
183
2.71
9.49
1.2
1.2
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
1218
10535
1.30
9.38
6.2
6.1
%
27.9
28.3
0.71
1142
9813
(3019069) Monocytes/100 leukocytes in Blood
1188
10244
1.30
9.36
6.4
6.3
%
8.4
8.5
0.19
1121
9592
(3006504) Eosinophils/100 leukocytes in Blood
1181
10184
1.29
9.27
6.2
6.0
%
2.8
2.8
0.29
1113
9485
(3001604) Monocytes [#/volume] in Blood
1247
10860
1.29
8.95
5.8
5.8
e9/l
0.6
0.6
0.28
1080
9411
(3006315) Basophils [#/volume] in Blood
1249
10901
1.28
8.72
5.9
5.9
e9/l
0.0
0.0
0.60
1082
9446
(3002173) Hemoglobin [Mass/volume] in Arterial blood
277
1912
1.50
8.70
7.4
8.9
g/l
123.9
121.0
1.49
266
1847
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
138
803
1.76
8.68
4.8
6.3
%
1.7
1.6
1.14
130
753
(3007930) Methemoglobin/Hemoglobin.total in Blood
137
802
1.75
8.45
4.7
6.3
%
0.9
0.9
0.55
129
751
(3013115) Eosinophils [#/volume] in Blood
1286
11295
1.28
8.42
6.0
6.1
e9/l
0.2
0.2
0.41
1138
9947
(3022096) Basophils/100 leukocytes in Blood
1142
9894
1.28
8.32
6.2
6.0
%
0.7
0.7
0.14
1075
9225
(3008152) Bicarbonate [Moles/volume] in Arterial blood
194
1262
1.58
7.98
6.3
7.5
mmol/l
25.1
24.6
1.18
180
1180
(3018010) Neutrophils/100 leukocytes in Blood
1184
10396
1.26
7.41
6.1
5.9
%
57.5
57.0
0.72
1112
9728
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
508
4008
1.33
7.35
1.5
1.5
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
50
219
2.31
7.03
1.2
1.2
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
1100
9654
1.24
6.67
11.4
9.2
e9/l
0.0
0.0
2.29
925
7905
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
109
643
1.73
6.61
2.3
2.7
—
—
—
0
0
(3019060) Gas panel - Arterial blood
194
1320
1.51
6.54
4.6
5.5
—
—
—
0
0
(40758558) Short blood count panel - Blood
675
5615
1.27
6.48
6.9
6.6
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
15
33
4.57
6.45
1.5
1.4
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
53
248
2.16
6.39
1.4
1.5
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
252
1816
1.43
6.34
4.1
4.0
—
—
—
0
0
(3036603) Volume of Urine
38
156
2.46
6.19
1.6
1.4
ml
2167.3
1946.1
—
8
29
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
227
1639
1.42
5.66
1.1
1.2
iu/ml
135.3
155.1
0.29
85
633
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
78
438
1.81
5.64
3.4
3.7
%
58.6
57.7
0.23
78
438
(3027273) Bicarbonate [Moles/volume] in Venous blood
141
928
1.55
5.58
3.3
3.1
mmol/l
26.0
25.4
1.07
134
896
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
115
723
1.62
5.53
2.0
2.0
u/l
7140.9
3680.5
0.36
23
294
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
492
4013
1.28
5.44
3.8
3.5
ng/l
103.3
365.9
4.02
363
2979
(40760888) Immunoglobulin light chains.free panel - Serum
79
451
1.78
5.43
4.1
3.8
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
223
1627
1.41
5.26
3.6
2.9
ng/l
171.3
182.5
0.16
204
1475
(3001122) Ferritin [Mass/volume] in Serum or Plasma
1084
9664
1.21
5.23
3.3
2.8
ug/l
108.5
114.5
0.46
999
8985
(3002032) Base excess in Venous blood by calculation
239
1769
1.39
5.18
3.3
3.6
mmol/l
2.2
2.0
0.25
190
1437
(3011985) Renin [Units/volume] in Plasma
56
292
1.94
5.12
2.0
1.4
mu/l
38.3
42.6
0.13
47
264
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
292
2239
1.34
5.06
5.7
4.4
u/l
232.9
249.2
1.27
276
2118
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
825
7196
1.22
4.91
3.7
3.2
u/l
28.8
33.2
2.25
783
6830
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
349
2758
1.31
4.90
3.0
2.5
%
21.8
23.0
0.72
282
2359
(40760892) CBC W Ordered Manual Differential panel - Blood
577
4867
1.24
4.73
4.6
4.5
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
372
2982
1.29
4.69
2.0
2.0
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
371
2975
1.29
4.66
2.8
2.4
g/l
2.4
2.4
0.09
343
2762
(3013512) EKG study
715
6176
1.22
4.65
3.5
3.7
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
851
7477
1.21
4.64
3.5
3.6
e6/l
71.5
103.5
0.66
607
5153
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
70
407
1.74
4.57
1.3
1.4
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
2477
24242
1.55
4.53
27.1
20.3
g/l
135.3
134.2
3.65
2459
23924
(3031040) Bacteria [#/volume] in Urine by Automated count
1549
14380
1.19
4.53
4.6
4.5
e6/l
2311.5
2443.5
0.03
19
189
(3024731) MCV [Entitic volume]
2476
24232
1.54
4.51
26.9
20.1
fl
90.1
91.0
24.04
2458
23918
(3035941) MCH [Entitic mass]
2476
24234
1.54
4.48
26.8
20.1
pg
30.0
30.3
14.58
2458
23917
(3007461) Platelets [#/volume] in Blood
2475
24223
1.53
4.47
27.1
20.2
e9/l
257.5
256.9
0.20
2439
23649
(3026361) Erythrocytes [#/volume] in Blood
2476
24236
1.54
4.46
27.0
20.1
e12/l
4.5
4.5
13.91
2436
23591
(3022948) Iron [Moles/volume] in Serum or Plasma
399
3250
1.27
4.42
2.9
2.4
umol/l
12.8
13.3
0.81
371
3011
(3010813) Leukocytes [#/volume] in Blood
2476
24239
1.53
4.42
27.0
20.2
e9/l
6.5
6.6
1.42
2438
23590
(3000991) Gas panel - Venous blood
219
1642
1.36
4.41
8.0
8.8
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
235
1784
1.35
4.37
3.4
3.5
kpa
5.9
5.8
0.27
226
1728
(3026782) Osmolality of Urine
485
4046
1.24
4.37
2.5
2.7
mosm/kgh2o
521.4
532.6
0.55
417
3444
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
12
31
3.88
4.25
1.3
1.1
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
654
5659
1.21
4.11
2.9
3.0
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
383
3134
1.26
4.08
2.9
2.1
s
29.6
29.6
0.04
373
3038
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
17
58
2.94
4.01
1.4
1.2
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
628
5435
1.21
3.92
4.3
4.2
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
621
5376
1.20
3.86
2.4
2.2
mg/l
3.0
3.0
0.05
534
4580
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
19
71
2.69
3.82
6.3
4.2
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
2083
19987
1.22
3.81
19.7
14.6
%
39.8
39.5
0.86
1483
14567
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
731
6431
1.19
3.80
2.3
2.1
u/l
149.2
204.1
1.58
703
6046
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
7
8
8.77
3.77
1.3
1.0
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
175
1302
1.37
3.73
2.2
1.7
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
163
1199
1.38
3.73
2.9
3.0
g/l
126.1
128.1
0.52
158
1166
(3041096) Erythrocytes [Presence] in Urine by Automated
660
5764
1.19
3.71
3.4
3.3
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
513
4381
1.21
3.66
2.6
2.5
e6/l
4.8
6.6
2.71
444
3830
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
63
381
1.67
3.64
1.3
1.2
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
374
3097
1.24
3.59
1.4
1.3
titre
427.0
557.8
1.08
71
673
(3005719) IgG [Mass/volume] in Serum or Plasma
211
1631
1.32
3.51
3.8
2.8
g/l
10.7
10.4
0.26
195
1485
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
32
158
2.04
3.50
1.2
1.1
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
75
479
1.58
3.50
2.9
3.0
mmol/l
25.1
25.0
0.07
67
417
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
65
401
1.64
3.49
1.5
1.7
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
31
152
2.05
3.46
1.2
1.2
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
65
404
1.62
3.40
2.7
2.8
kpa
8.2
8.1
0.11
58
371
(3024980) IgG subclass 4 [Mass/volume] in Serum
56
335
1.69
3.39
1.9
1.6
g/l
0.8
0.7
0.12
38
257
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
257
2050
1.28
3.39
1.9
2.2
g/l
0.2
0.2
2.49
249
1918
(3002582) Erythrocytes [#/volume] in Urine
708
6266
1.18
3.37
3.1
3.1
e6/l
47.7
92.3
1.36
543
4749
(40767503) Oxygen content in Capillary blood by calculation
65
408
1.61
3.28
2.6
2.6
%
15.6
16.4
0.73
39
197
(3034860) Kappa light chains.free [Mass/volume] in Serum
91
617
1.49
3.27
4.2
3.7
mg/l
42.7
62.4
0.87
72
509
(3014576) Chloride [Moles/volume] in Serum or Plasma
307
2514
1.25
3.26
6.5
7.0
mmol/l
104.0
104.3
0.49
300
2461
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
214
2704
0.77
3.25
4.6
4.5
%
32.4
32.7
0.18
143
1833
(3011412) CD3 cells [#/volume] in Blood
37
198
1.88
3.25
2.1
2.3
e9/l
1.1
1.1
0.06
26
121
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
301
2462
1.25
3.23
2.3
2.6
umol/l
8.4
7.7
0.18
264
2131
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
282
2291
1.26
3.21
1.9
1.7
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
55
333
1.67
3.20
2.7
2.8
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
763
6819
1.17
3.20
2.6
2.5
u/l
57.2
57.5
0.02
704
6291
(3042631) Mycobacterium sp identified in Specimen
46
265
1.75
3.20
3.8
2.6
—
—
—
0
0
(3017704) Immunofixation for Urine
24
111
2.17
3.12
1.6
1.7
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
127
928
1.39
3.07
2.0
1.9
u/l
35.8
39.1
1.24
113
833
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
88
601
1.48
3.07
4.0
3.6
ratio
1.1
1.6
—
6
49
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
90
618
1.47
3.06
4.2
3.7
mg/l
28.8
57.6
1.43
72
511
(3021440) Promyelocytes/100 leukocytes in Blood
218
1729
1.28
3.03
4.1
4.2
%
0.2
0.1
0.74
67
446
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
140
1044
1.36
3.00
9.4
10.4
mmol/l
24.7
24.4
0.60
133
987
(3017181) Myelocytes/100 leukocytes in Blood
227
1813
1.28
2.99
4.1
4.1
%
1.6
0.9
1.81
73
482
(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis
5
5
10.02
2.98
1.8
1.4
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
2379
23270
1.29
2.98
12.4
10.4
u/l
24.8
25.3
1.14
2321
22520
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
255
2068
1.26
2.96
1.4
1.4
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
107
765
1.42
2.95
3.0
3.5
u/ml
360.6
2034.9
0.68
89
653
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
872
7913
1.15
2.94
3.5
3.5
ng/l
49.5
113.6
0.51
557
5177
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
30
155
1.95
2.94
1.3
2.0
%
18.8
13.4
1.04
12
63
(3007164) IgA [Mass/volume] in Serum or Plasma
501
4355
1.19
2.92
1.7
1.4
g/l
2.3
2.3
0.11
319
2648
(3026008) Bacteria identified in Urine by Culture
754
6774
1.16
2.91
3.0
3.1
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
66
429
1.55
2.91
2.0
1.6
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
1166
10807
1.14
2.89
3.8
3.7
estimate
0.0
0.0
1.08
255
1934
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
150
1139
1.34
2.87
2.5
2.4
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
279
2296
1.24
2.85
1.9
1.7
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
46
275
1.68
2.84
1.5
1.4
pmol/l
311.6
303.5
0.08
37
215
(3030467) Casts [#/volume] in Urine by Automated count
649
5779
1.16
2.81
3.0
3.0
e6/l
0.4
0.4
0.14
496
4316
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
894
8157
1.15
2.76
4.0
3.9
—
—
—
0
0
(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method
5
6
8.35
2.75
9.6
15.3
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
301
2508
1.23
2.74
1.8
1.7
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
667
5972
1.16
2.67
1.7
1.7
mmol/l
1.3
1.4
1.75
554
5031
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
41
242
1.71
2.67
1.1
1.2
u/l
85.3
54.3
0.75
30
170
(3028026) IgM [Mass/volume] in Serum or Plasma
164
1277
1.30
2.65
2.6
1.8
g/l
1.5
1.4
0.09
149
1163
(3021601) Nitrite [Presence] in Urine by Test strip
1150
10693
1.14
2.64
5.1
5.0
estimate
0.0
0.0
0.50
252
1978
(3010421) pH of Blood
80
555
1.46
2.63
4.9
3.8
ph
7.4
7.4
0.05
64
453
(3028192) IgG subclass 2 [Mass/volume] in Serum
36
207
1.75
2.58
1.8
1.5
g/l
2.7
2.8
0.09
24
148
(3024139) IgG subclass 3 [Mass/volume] in Serum
36
207
1.75
2.58
1.8
1.5
g/l
0.3
0.4
0.44
23
149
(3027135) IgG subclass 1 [Mass/volume] in Serum
36
207
1.75
2.58
1.8
1.5
g/l
7.3
6.9
0.30
22
149
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
85
599
1.43
2.58
1.8
1.7
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
150
1159
1.31
2.57
1.4
1.3
iu/l
31.2
30.4
0.12
130
996
(3025159) Blasts/100 leukocytes in Blood
203
1632
1.26
2.56
4.0
4.2
%
0.2
0.5
0.51
52
380
(1616796) Gas panel - Central venous blood
64
427
1.51
2.55
4.9
3.6
—
—
—
0
0
(3022145) Colonoscopy Study observation
300
2519
1.22
2.55
1.4
1.3
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
206
1661
1.26
2.54
4.0
3.9
%
1.7
0.6
1.05
45
348
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
384
3304
1.19
2.51
2.1
1.8
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
28
150
1.88
2.51
1.3
2.0
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
20
95
2.11
2.48
3.3
3.4
—
—
—
0
0
(4062490)
36
211
1.72
2.43
1.8
1.5
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
215
1754
1.25
2.41
7.1
7.4
mmol/l
1.2
1.3
0.73
206
1696
(3012501) Base excess in Blood by calculation
67
458
1.48
2.40
5.4
4.0
mmol/l
2.7
2.6
0.13
47
319
(3042111) Morphology [Interpretation] in Bone marrow Narrative
52
337
1.55
2.38
1.3
1.6
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
42
259
1.63
2.36
3.7
2.7
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
82
587
1.41
2.31
2.4
2.0
mg/l
10.9
11.6
0.35
76
542
(3045414) Leukocytes [Presence] in Urine
73
1024
0.70
2.30
2.0
1.9
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
9
28
3.22
2.30
5.7
2.8
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
47
301
1.57
2.28
1.3
1.3
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
119
909
1.32
2.25
1.4
1.3
u/ml
2.6
1.8
0.14
11
72
(3028308) Erythrocytes [#/volume] in Pleural fluid
32
186
1.73
2.24
1.6
1.3
e6/l
28249.5
101769.0
0.93
20
104
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
23
121
1.91
2.20
1.3
1.1
u/l
71.6
82.6
0.53
17
94
(3035350) Ketones [Presence] in Urine by Test strip
1136
10637
1.12
2.20
3.8
3.7
estimate
0.0
0.0
0.00
255
1953
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
188
1530
1.25
2.17
1.6
1.6
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
180
1461
1.25
2.14
2.0
3.5
u/ml
42.2
49.8
0.27
175
1414
(3004809) Band form neutrophils/100 leukocytes in Blood
49
323
1.53
2.11
4.4
3.3
%
2.4
1.3
0.81
38
259
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
563
5059
1.14
2.11
1.3
1.3
u/ml
2.0
1.6
0.40
153
1358
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
514
4594
1.15
2.08
1.6
1.7
pmol/l
450.5
41475932.6
4.82
411
3836
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
16
76
2.11
2.02
1.5
2.8
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
1569
15006
1.12
2.01
4.6
4.4
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
68
486
1.41
1.98
3.2
3.7
u/ml
23.5
31.2
0.73
68
473
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
85
632
1.36
1.96
1.0
1.1
u/ml
1.8
4.9
1.33
14
82
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
88
658
1.35
1.96
1.7
1.7
g/l
0.3
0.2
1.12
80
624
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
57
396
1.45
1.94
1.6
1.4
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
1517
14498
1.11
1.93
3.1
3.1
u/l
42.9
45.7
0.80
1417
13549
(3017446) Testosterone [Moles/volume] in Serum or Plasma
127
1003
1.28
1.92
2.1
2.1
nmol/l
10.4
12.1
1.39
110
886
(3017732) Neutrophils [#/volume] in Blood
186
1537
1.23
1.90
2.8
2.9
e9/l
3.9
4.1
0.29
154
1228
(3052851) Hemolysis interference index of Serum or Plasma
87
653
1.34
1.90
3.1
3.2
—
—
—
0
0
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
22
121
1.83
1.88
1.3
1.1
u/l
14.1
24.6
1.31
15
91
(3029937) Albumin [Presence] in Urine by Test strip
622
5668
1.13
1.87
4.3
4.1
estimate
0.0
0.0
1.28
245
1947
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
60
835
0.71
1.86
1.4
1.5
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
38
245
1.56
1.84
1.1
1.3
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
31
489
0.63
1.82
1.3
1.5
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
61
435
1.41
1.82
2.4
2.3
g/l
122.4
129.7
1.25
51
313
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
90
684
1.33
1.82
1.6
1.7
g/l
1.2
1.2
0.06
82
650
(3048929) Epstein Barr virus Ab [Presence] in Serum
81
607
1.35
1.80
1.4
1.2
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
48
328
1.47
1.79
1.3
1.4
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
357
3148
1.16
1.76
1.3
1.2
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
9
36
2.51
1.74
1.1
1.2
ng/l
63.4
76.9
—
9
36
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
12
54
2.23
1.74
1.3
1.1
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
170
1409
1.22
1.71
2.8
2.5
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
14
68
2.06
1.70
1.2
1.3
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
174
1447
1.22
1.70
1.3
1.3
au/ml
70.5
49.6
—
9
71
(21494814) CD8 cells/100 lymphocytes in Specimen
17
89
1.92
1.70
1.3
1.9
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
315
2760
1.16
1.69
2.4
2.2
ug/g
110.6
116.6
0.19
247
2184
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
15
75
2.01
1.69
1.2
1.8
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
36
539
0.66
1.68
1.4
1.4
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
35
227
1.55
1.68
2.1
1.6
—
—
—
0
0
(1002224) Polysomnography panel
115
916
1.27
1.66
1.0
1.1
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
211
1792
1.19
1.66
1.2
1.2
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
39
260
1.51
1.66
1.1
1.1
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
55
393
1.41
1.65
4.8
5.8
iu/ml
1351.4
350.4
—
8
58
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
16
83
1.93
1.64
1.2
1.3
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
203
1721
1.19
1.63
9.0
7.6
mmol/l
9.5
9.3
0.15
189
1648
(3013139) Helicobacter pylori Ag [Presence] in Stool
180
1510
1.21
1.62
1.3
1.2
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
56
403
1.40
1.62
1.4
1.2
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
188
1584
1.20
1.62
2.4
2.4
au/ml
16.1
24.2
0.97
15
94
(3023199) Leukocytes [#/volume] in Pleural fluid
33
214
1.55
1.59
1.5
1.3
e6/l
1678.6
1908.5
0.23
26
149
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
67
500
1.35
1.56
1.3
1.3
u/ml
16.6
44.6
—
8
57
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
22
129
1.71
1.56
1.1
1.2
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
20
114
1.76
1.56
2.3
1.6
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
26
160
1.63
1.55
2.3
1.6
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
12
57
2.11
1.55
1.1
1.1
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
393
3522
1.14
1.55
2.6
2.6
e6/l
1.0
1.2
0.76
218
1965
(3003434) Protein [Mass/volume] in Pleural fluid
35
232
1.52
1.54
1.5
1.4
g/l
33.2
32.3
0.16
35
206
(3023520) Reticulocytes [#/volume] in Blood
190
1612
1.19
1.53
2.8
2.6
e9/l
74.2
72.1
0.26
140
1217
(3045788) Cell count panel - Pleural fluid
27
169
1.60
1.52
1.7
1.4
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
537
4911
1.12
1.51
2.1
1.8
mg/l
1.2
1.1
0.21
416
3737
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
7
27
2.60
1.51
6.9
2.7
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
599
5513
1.11
1.50
2.7
2.5
umol/l
2177.0
5066.3
1.68
520
4779
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
24
146
1.65
1.50
1.5
1.7
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
197
1681
1.19
1.49
3.0
2.8
g/l
67.0
66.6
0.33
184
1533
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
15
79
1.90
1.49
1.0
1.2
%
122.7
109.7
1.07
15
70
(3022475) Manganese [Moles/volume] in Blood
5
16
3.13
1.44
1.2
1.4
—
—
—
0
0
(3003338) MCHC [Mass/volume]
1904
18535
1.10
1.43
23.6
17.5
g/l
332.2
331.8
1.53
1896
18408
(3032352) Blasts [#/volume] in Cerebral spinal fluid
6
22
2.73
1.43
2.0
2.3
—
—
—
0
0
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
24
150
1.61
1.38
1.3
1.4
u/l
264.6
336.2
0.64
24
144
(3003327) Ova and parasites identified in Stool by Light microscopy
90
715
1.27
1.37
1.6
1.7
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
26
166
1.57
1.37
1.9
1.7
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
6
23
2.61
1.36
1.8
1.4
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
6
23
2.61
1.36
5.5
9.7
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
930
8787
1.09
1.35
2.0
2.0
pmol/l
95.8
96.9
0.26
467
4409
(3004451) EKG impression Narrative
17
97
1.76
1.35
1.3
1.3
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
701
6541
1.10
1.34
3.2
3.2
mmol/l
7.1
7.2
0.08
592
5513
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
79
620
1.28
1.33
2.6
3.5
u/ml
0.3
0.4
1.06
47
354
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
12
61
1.97
1.32
1.3
1.2
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
19
113
1.69
1.31
1.5
1.3
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
38
533
0.71
1.31
1.9
2.2
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
9
43
2.10
1.30
1.4
1.5
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
12
62
1.94
1.27
1.0
1.0
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
501
4609
1.11
1.27
4.4
4.1
kg/l
1.0
1.0
0.15
91
654
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
477
4378
1.11
1.27
1.4
1.4
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
8
35
2.29
1.26
1.5
1.0
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
8
35
2.29
1.26
1.5
1.0
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
8
35
2.29
1.26
1.5
1.0
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
32
459
0.69
1.26
1.2
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
32
458
0.69
1.25
1.2
1.4
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
31
211
1.47
1.25
1.3
1.2
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
47
346
1.37
1.24
1.7
1.4
nmol/l
0.3
0.3
0.85
39
264
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
19
115
1.66
1.24
2.3
1.6
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
25
375
0.66
1.24
1.7
1.6
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
360
3257
1.12
1.24
2.7
2.8
e6/l
4.0
3.1
0.78
190
1709
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
32
457
0.70
1.24
1.2
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
32
457
0.70
1.24
1.2
1.4
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
94
763
1.24
1.22
2.6
2.0
ug/l
18.4
2.0
0.53
81
677
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
66
513
1.29
1.22
2.3
1.6
—
—
—
0
0
(3033923) Metanephrine [Moles/time] in 24 hour Urine
11
56
1.97
1.22
1.0
1.1
umol/24h
0.6
0.7
—
5
36
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
19
116
1.64
1.21
1.5
1.3
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
216
2453
0.87
1.19
1.6
1.8
%
1.4
1.4
0.21
187
2156
(3016018) Differential panel - Cerebral spinal fluid
32
222
1.45
1.19
1.6
1.5
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
6
26
2.31
1.18
1.2
1.3
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
246
2181
1.14
1.18
2.9
2.6
%
1.8
1.8
0.05
218
1948
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
21
133
1.58
1.17
2.2
1.5
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
416
3809
1.11
1.16
1.8
1.7
nmol/l
1161.5
1196.6
0.33
334
2872
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
6
129
0.46
1.16
1.3
1.3
—
—
—
0
0
(3019779) Phenytoin [Moles/volume] in Serum or Plasma
0
34
0.00
1.16
0.0
4.2
—
41.6
—
0
26
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
8
39
2.05
1.15
2.1
2.2
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
531
4928
1.10
1.14
1.5
1.5
nmol/l
22.1
21.2
0.22
474
4198
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
48
361
1.34
1.13
1.4
1.4
u/ml
106.3
110.3
0.15
14
65
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
5
111
0.45
1.13
2.0
5.9
—
59.0
—
0
24
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
82
664
1.24
1.11
1.4
1.3
u/ml
12.7
32.6
—
7
42
(3009214) Lutropin [Units/volume] in Serum or Plasma
65
512
1.28
1.11
1.5
1.3
u/l
14.1
12.0
0.52
49
413
(3052592) Norovirus Ag [Presence] in Stool
8
41
1.95
1.08
1.5
1.4
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
32
227
1.41
1.08
2.6
2.4
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
69
859
0.80
1.07
2.2
1.7
mg/l
3.7
3.9
0.08
49
611
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
15
89
1.69
1.07
1.0
1.1
iu/ml
120.9
193.9
0.79
15
89
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
10
52
1.93
1.06
1.1
1.1
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
88
723
1.22
1.06
1.6
2.0
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
44
332
1.33
1.03
1.4
1.5
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
39
289
1.35
1.03
2.1
1.5
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
29
204
1.43
1.03
1.6
2.1
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
74
599
1.24
1.02
1.3
1.2
titre
80.0
92.5
0.30
11
44
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
75
915
0.81
0.99
1.4
1.5
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
437
4048
1.10
0.99
5.3
4.8
ug/l
2.1
2.5
1.14
396
3613
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
49
379
1.30
0.98
1.4
1.2
u/ml
314.1
262.8
0.55
28
239
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
9
50
1.80
0.96
1.0
1.1
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
26
182
1.43
0.96
1.6
1.4
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
11
186
0.59
0.95
1.2
1.1
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
90
1072
0.83
0.94
3.4
3.3
—
—
—
0
0
(3011648) Oxygen content in Venous blood
23
158
1.46
0.93
1.7
2.3
%
10.1
10.7
0.31
23
158
(21494755) Public health laboratory ask at order entry panel
178
2007
0.88
0.93
1.3
1.3
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
25
175
1.43
0.92
1.5
2.3
u/field
2.0
2.2
—
10
78
(3024928) Oxygen saturation in Venous blood
53
420
1.27
0.90
2.5
3.0
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
21
143
1.47
0.89
2.9
2.5
e6/l
740.2
711.8
—
9
59
(3003181) Sodium [Moles/volume] in Urine
49
385
1.28
0.89
1.2
1.3
mmol/l
65.7
60.2
0.35
36
310
(40768446) Kidney Pathology biopsy report
12
71
1.69
0.88
1.6
1.6
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
29
392
0.74
0.87
1.3
1.5
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
53
423
1.26
0.86
1.3
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
53
423
1.26
0.86
1.3
1.3
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
108
928
1.17
0.85
2.5
2.6
%
1.1
1.2
1.10
108
921
(40768793) Breast Pathology biopsy report
78
651
1.20
0.85
1.3
1.3
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
8
139
0.57
0.83
1.4
1.3
—
694.0
—
0
10
(3021788) Differential panel - Synovial fluid
48
381
1.26
0.82
1.6
1.6
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
193
1732
1.12
0.82
3.2
2.6
ml/min/173m2
63.2
67.8
0.88
77
687
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
21
146
1.44
0.82
1.5
1.6
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
175
1953
0.89
0.80
1.8
1.9
—
—
—
0
0
(40761535) Cells panel - Urine sediment
154
1732
0.88
0.80
3.9
3.4
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
47
374
1.26
0.80
2.7
1.6
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
0
26
0.00
0.78
0.0
1.2
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
15
98
1.53
0.78
2.2
1.6
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
106
917
1.16
0.78
3.2
3.9
mmol/l
24.2
24.3
0.02
95
825
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
14
90
1.56
0.78
3.6
1.9
ug/l
22.4
108.8
0.46
14
77
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
21
148
1.42
0.77
1.6
1.6
u/l
8.5
7.3
—
8
76
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
47
376
1.25
0.77
1.8
1.4
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
26
191
1.36
0.77
4.6
3.1
%
52.9
56.7
0.19
14
130
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
26
191
1.36
0.77
1.5
1.3
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
164
1465
1.13
0.77
3.2
2.9
kpa
5.0
4.6
1.02
156
1414
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
6
34
1.77
0.76
1.8
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
29
382
0.76
0.76
1.2
1.4
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
45
360
1.25
0.74
1.2
1.1
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
29
380
0.76
0.74
1.2
1.4
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
646
6152
1.07
0.74
3.3
3.2
mg/l
1199.4
349.1
1.83
398
3723
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
26
346
0.75
0.74
1.6
1.7
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
9
55
1.64
0.73
4.2
4.4
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
144
1281
1.13
0.73
1.2
1.2
—
—
—
0
0
(4034850)
83
710
1.17
0.72
12.6
8.9
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
45
362
1.25
0.72
1.2
1.1
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
78
664
1.18
0.71
1.4
1.4
ug/g
326.3
292.0
0.90
49
369
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
7
40
1.75
0.71
1.0
1.2
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
7
40
1.75
0.71
1.0
1.1
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
61
508
1.21
0.71
2.4
1.6
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
5
26
1.92
0.70
1.4
1.1
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
5
26
1.92
0.70
1.6
2.8
u/field
0.8
0.8
—
5
26
(3034274) Bile acid [Moles/volume] in Serum --fasting
17
240
0.71
0.70
1.2
2.0
umol/l
4.0
6.3
0.93
12
168
(3024932) HLA-DR beta [Type]
9
58
1.55
0.69
1.0
1.2
—
—
—
0
0
(3035880) pH of Pleural fluid
14
93
1.51
0.69
1.2
1.3
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
30
230
1.31
0.69
1.2
1.2
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
224
2051
1.10
0.69
2.6
2.3
u/l
30.4
38.7
2.86
190
1747
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
42
337
1.25
0.69
1.0
1.1
u/ml
1.9
2.9
0.48
26
153
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
5
27
1.85
0.68
1.0
1.2
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
7
43
1.63
0.66
1.0
1.5
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
56
466
1.21
0.66
1.4
1.6
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
5
94
0.53
0.66
1.0
1.2
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
5
28
1.79
0.66
3.2
2.0
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
200
2187
0.91
0.66
1.9
2.0
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
105
1191
0.88
0.65
1.8
1.7
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
27
206
1.31
0.65
1.4
1.7
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
72
615
1.18
0.65
1.4
1.3
u/ml
3.8
9.3
1.36
14
118
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
16
112
1.43
0.63
3.3
1.7
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
16
112
1.43
0.63
3.3
1.7
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
16
112
1.43
0.63
3.3
1.7
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
16
112
1.43
0.63
3.3
1.7
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
12
79
1.52
0.62
1.2
1.4
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
256
2373
1.09
0.62
1.7
1.5
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
78
674
1.16
0.62
1.7
1.6
iu/ml
0.5
0.1
0.43
21
140
(4146454)
17
234
0.72
0.62
2.5
2.7
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
6
103
0.58
0.62
1.0
1.5
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
80
693
1.16
0.62
2.5
2.5
—
—
—
0
0
(3024263) Appearance of Synovial fluid
6
105
0.57
0.61
2.5
1.8
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
5
30
1.67
0.61
1.2
1.1
—
—
—
0
0
(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum
0
20
0.00
0.60
0.0
1.0
—
0.3
—
0
13
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
21
0.00
0.60
0.0
1.2
—
—
—
0
0
(3023383) Lactate [Moles/volume] in Pleural fluid
8
52
1.54
0.59
1.0
1.2
mmol/l
2.5
3.2
—
8
46
(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid
0
22
0.00
0.59
0.0
1.0
—
15.7
—
0
7
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
111
989
1.13
0.58
1.6
1.7
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
23
0.00
0.58
0.0
1.2
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
346
3256
1.07
0.58
4.4
4.2
%
22.5
21.2
0.91
176
1551
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
36
291
1.24
0.58
1.9
1.5
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
15
106
1.42
0.57
1.5
1.8
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
2027
20019
1.06
0.57
5.8
5.6
mmol/mol
39.3
39.5
0.33
1888
18563
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
59
503
1.18
0.57
1.4
1.3
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
107
1198
0.89
0.57
1.4
1.4
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
58
494
1.18
0.56
1.4
1.4
e6/l
29.3
20.3
0.27
38
380
(3020682) Albumin/Creatinine [Ratio] in Urine
672
6462
1.05
0.56
4.1
4.0
mg/mmol
10.3
8.0
0.41
406
3935
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
84
737
1.14
0.56
1.8
1.9
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
8
55
1.46
0.56
1.1
1.1
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
58
495
1.18
0.55
1.5
1.5
e6/l
1252.9
1344.8
0.04
43
403
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
70
607
1.16
0.55
1.4
1.3
u/ml
1.8
7.0
—
9
69
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
120
1331
0.90
0.55
1.3
1.4
—
—
—
0
0
(3024471) HLA-A [Type]
9
60
1.50
0.54
1.0
1.0
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
9
61
1.48
0.53
4.7
3.0
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
83
732
1.14
0.53
1.7
1.6
mu/l
324.1
305.6
0.19
77
658
(3043410) Blood group antigens tested for on Red Blood Cells
9
63
1.43
0.52
3.8
1.2
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
14
192
0.73
0.52
1.4
1.0
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
20
152
1.32
0.52
1.3
1.2
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
18
237
0.76
0.51
2.1
2.2
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
67
583
1.15
0.51
1.2
1.3
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
67
583
1.15
0.51
1.1
1.2
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
17
126
1.35
0.51
2.1
2.7
%
44.4
41.7
—
5
39
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
33
402
0.82
0.51
1.4
1.5
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
18
135
1.34
0.51
1.1
1.0
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
598
5750
1.05
0.51
3.1
3.0
ng/l
1203.9
1194.3
0.02
507
4857
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
139
1268
1.10
0.50
1.7
1.8
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
13
92
1.42
0.50
1.1
1.2
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
10
67
1.49
0.49
1.9
1.7
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
18
235
0.76
0.49
1.1
1.1
u/ml
0.2
0.3
—
5
59
(3006442) Creatine [Moles/volume] in Serum or Plasma
19
145
1.31
0.48
1.5
1.5
—
63.9
—
0
14
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
104
937
1.11
0.48
1.3
1.4
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
30
244
1.23
0.48
2.6
2.2
pg
32.7
32.1
0.36
30
244
(40768800) Prostate Pathology biopsy report
19
245
0.77
0.48
1.1
1.2
—
—
—
0
0
(3008898) HLA-B27 [Presence]
89
795
1.12
0.48
1.1
1.1
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
35
290
1.21
0.47
1.1
1.3
mmol/l
7.7
7.3
0.37
25
211
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
7
47
1.49
0.47
1.0
1.2
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
7
47
1.49
0.47
1.0
1.3
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
11
154
0.71
0.47
1.0
1.1
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
12
85
1.41
0.47
1.3
1.0
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
20
255
0.78
0.46
1.1
1.1
u/ml
0.4
3.7
—
5
99
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
20
155
1.29
0.46
1.3
1.3
—
—
—
0
0
(3017315) Amylase [Enzymatic activity/volume] in Urine
15
111
1.35
0.46
1.0
1.3
u/l
176.3
332.8
0.84
15
101
(3020891) Body temperature
91
816
1.12
0.46
4.9
4.4
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
134
1227
1.10
0.46
4.2
3.5
kpa
5.2
5.2
0.08
123
1140
(3000492) Spirometry study
195
2092
0.93
0.46
1.5
1.5
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
16
120
1.34
0.46
1.3
1.2
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
5
81
0.62
0.45
1.0
1.2
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
379
3612
1.06
0.45
1.9
1.8
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
1436
14108
1.04
0.45
3.2
3.0
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
28
341
0.82
0.45
1.1
1.1
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
25
201
1.25
0.45
1.1
1.2
—
—
—
0
0
(40768443) Skin Pathology biopsy report
105
952
1.11
0.44
1.2
1.2
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
129
1182
1.10
0.44
1.5
1.5
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
84
753
1.12
0.44
2.4
2.5
g/l
10.2
10.1
0.09
66
648
(3009343) pH of Capillary blood
132
1213
1.09
0.43
4.2
3.5
ph
7.4
7.4
0.03
29
149
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
94
849
1.11
0.43
1.7
1.6
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
29
348
0.83
0.41
1.7
1.8
—
—
—
0
0
(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.0
—
2.2
—
0
9
(3036312) Salmon IgE Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.0
—
0.2
—
0
9
(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.0
—
0.0
—
0
10
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum
0
17
0.00
0.40
0.0
1.0
—
0.0
—
0
11
(3002621) Streptococcal DNAse B [Units/volume] in Serum
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
10
138
0.72
0.40
9.2
3.4
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
5
34
1.47
0.40
1.0
1.1
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
8
60
1.33
0.40
1.4
1.6
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
20
159
1.26
0.40
1.6
2.2
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
69
616
1.12
0.40
4.0
3.8
mmol/l
3.8
3.8
0.20
64
579
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
8
61
1.31
0.39
1.6
1.2
pmol/l
683.0
304.6
—
8
44
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
2191
22068
0.95
0.38
5.0
4.8
mmol/l
2.8
2.8
0.30
2043
20411
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
5
36
1.39
0.38
1.0
1.2
umol/24h
1.6
1.8
—
5
36
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
12
89
1.35
0.38
1.8
1.8
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
24
197
1.22
0.37
1.7
1.5
%
32.1
34.4
0.12
14
119
(4198724)
9
68
1.32
0.37
2.8
1.9
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
22
179
1.23
0.37
1.3
1.2
u/ml
0.2
0.5
0.61
14
77
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
5
37
1.35
0.37
1.0
1.0
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
39
449
0.87
0.36
1.7
3.0
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
25
299
0.83
0.35
1.2
1.5
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
2154
21695
0.96
0.35
4.5
4.4
mmol/l
4.7
4.8
1.81
2019
20177
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
5
79
0.63
0.35
4.0
3.0
umol/l
34.4
29.5
—
5
57
(3014148) Varicella zoster virus Ab [Titer] in Serum
30
254
1.18
0.35
1.0
1.2
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
30
352
0.85
0.35
1.1
1.1
iu/ml
50.0
1613.7
—
6
81
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
38
329
1.16
0.35
2.0
1.4
—
—
—
0
0
(4094501)
53
595
0.89
0.34
1.0
1.1
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
2139
21542
0.96
0.34
4.4
4.3
mmol/l
1.5
1.5
5.09
1992
19920
(4306422)
29
340
0.85
0.34
1.2
1.2
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
17
136
1.25
0.33
1.0
1.1
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
23
191
1.21
0.33
2.9
1.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
23
191
1.21
0.33
2.9
1.6
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
23
191
1.21
0.33
2.9
1.6
—
—
—
0
0
(4010399)
144
1536
0.93
0.33
1.4
1.4
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
33
285
1.16
0.32
1.5
1.2
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
33
285
1.16
0.32
2.0
1.4
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
15
119
1.26
0.31
1.3
1.4
u/l
10.9
13.8
1.47
15
112
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
258
2467
1.05
0.31
1.6
1.7
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
14
175
0.80
0.30
1.4
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
14
175
0.80
0.30
1.4
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
14
175
0.80
0.30
1.4
1.2
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
125
1169
1.07
0.30
4.3
3.4
mmol/l
2.8
1.8
2.72
100
887
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
32
277
1.16
0.30
3.5
2.1
u/ml
6.5
19.6
0.44
32
264
(3034426) Prothrombin time (PT)
10
75
1.33
0.30
1.1
1.2
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
7
55
1.27
0.30
1.0
1.1
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
68
620
1.10
0.30
3.1
2.4
%
183.4
182.2
0.04
62
588
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
16
196
0.82
0.30
1.2
1.3
nmol/l
1.4
1.5
0.13
16
173
(3000012) Reticulocyte production index
13
102
1.28
0.30
1.4
1.6
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
24
282
0.85
0.29
1.0
1.1
u/ml
1.9
2.6
—
9
103
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
14
174
0.80
0.29
1.4
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
14
174
0.80
0.29
1.4
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
14
174
0.80
0.29
1.4
1.2
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
39
344
1.14
0.29
1.4
1.2
u/ml
1.7
3.3
0.78
14
103
(3038177) Helicobacter pylori Ab [Presence] in Serum
41
363
1.13
0.29
1.2
1.2
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
155
1464
1.06
0.29
1.3
1.3
u/ml
106.9
189.6
1.87
143
1345
(37021550) Renin [Units/volume] in Plasma --upright
7
57
1.23
0.29
1.3
1.3
mu/l
110.5
66.0
—
7
46
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
24
281
0.85
0.29
1.4
1.5
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
10
129
0.77
0.28
1.2
1.4
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
12
94
1.28
0.28
1.4
1.4
pmol/l
147.1
331.0
—
7
33
(3044927) Protein electrophoresis panel - Urine
25
214
1.17
0.27
1.2
1.2
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
8
63
1.27
0.27
1.9
2.0
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
27
233
1.16
0.27
1.0
1.1
—
—
—
0
0
(4268621)
27
233
1.16
0.27
2.1
2.2
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
8
64
1.25
0.27
1.1
1.1
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
53
480
1.11
0.27
1.3
1.3
u/ml
17.1
3.8
—
7
39
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
30
262
1.15
0.26
1.8
1.6
%
65.9
57.7
0.57
18
161
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
88
818
1.08
0.26
2.4
2.5
g/l
3.9
3.8
0.44
57
598
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
88
819
1.08
0.26
2.5
2.5
g/l
7.3
7.4
0.20
60
630
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
88
819
1.08
0.26
2.4
2.5
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
270
2600
1.04
0.25
1.7
1.4
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
38
339
1.12
0.25
1.4
1.2
u/ml
5.6
5.1
0.07
19
135
(3044290) Cell count panel - Cerebral spinal fluid
49
445
1.10
0.24
1.4
1.5
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
2064
20764
0.97
0.24
3.9
3.9
mmol/l
1.3
1.3
0.20
1910
19082
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
66
609
1.09
0.24
4.5
2.6
g/l
3.5
3.6
0.24
61
578
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
6
82
0.73
0.24
1.2
1.0
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
30
339
0.88
0.24
1.0
1.1
u/ml
0.9
1.3
0.18
19
141
(3051593) INR in Capillary blood by Coagulation assay
6
85
0.71
0.24
1.2
13.8
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
5
38
1.32
0.23
2.2
1.7
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
264
2549
1.04
0.23
19.4
22.6
inr
1.1
1.3
1.16
48
369
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
31
275
1.13
0.23
1.1
1.1
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
189
1971
0.96
0.23
1.6
1.7
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
10
125
0.80
0.23
1.0
1.2
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
19
162
1.17
0.22
1.1
1.1
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
7
93
0.75
0.22
2.0
1.8
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
60
649
0.92
0.22
2.2
2.4
g/l
38.7
38.0
0.46
52
565
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
44
400
1.10
0.22
1.2
1.2
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
20
172
1.16
0.22
1.4
1.2
—
—
—
0
0
(40768441) Liver Pathology biopsy report
20
172
1.16
0.22
1.1
1.3
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
5
41
1.22
0.22
1.2
1.3
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
5
41
1.22
0.22
1.2
3.4
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
34
378
0.90
0.21
1.3
1.3
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
32
286
1.12
0.21
1.3
1.3
u/ml
51.9
46.1
—
5
17
(3006653) Thiamine [Moles/volume] in Blood
10
124
0.81
0.21
1.1
1.4
nmol/l
124.4
133.9
—
10
124
(40760410) HLA-B [Type] by High resolution
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3013862) HLA-DP [Type]
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay
0
10
0.00
0.21
0.0
2.4
—
4.7
—
0
10
(3007700) Barley IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.1
—
0.1
—
0
6
(3018001) Oat IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.0
—
0.1
—
0
5
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.5
—
13.7
—
0
12
(4281824)
25
283
0.88
0.21
1.1
1.1
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
25
220
1.14
0.21
1.6
1.6
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
25
220
1.14
0.21
6.9
3.7
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
27
239
1.13
0.21
1.3
1.5
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
5
43
1.16
0.21
1.8
2.2
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
70
653
1.07
0.21
1.7
1.9
—
—
—
0
0
(3007542) Rye IgE Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.1
—
0.2
—
0
6
(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid
0
13
0.00
0.21
0.0
7.9
—
190.9
—
0
8
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
93
877
1.06
0.21
2.1
1.8
g/l
1.5
1.5
0.09
80
767
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
26
230
1.13
0.20
1.4
1.5
ug/l
1.4
4.1
1.69
20
197
(3010937) Rubella virus Ab [Presence] in Serum
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
59
548
1.08
0.20
1.3
1.4
—
17.3
—
0
13
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
32
289
1.11
0.19
1.6
1.4
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
54
581
0.93
0.19
2.0
2.5
g/l
0.0
0.0
0.00
49
541
(3022621) pH of Urine by Test strip
152
1460
1.04
0.18
3.2
3.0
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
126
1205
1.05
0.18
1.0
1.0
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
2137
21276
1.03
0.18
4.8
4.5
mmol/l
5.9
5.9
0.83
1983
19472
(3000764) Benzodiazepines [Presence] in Urine
70
658
1.07
0.18
1.7
2.0
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
37
404
0.91
0.18
1.3
1.3
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
14
119
1.18
0.17
1.1
1.2
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
7
61
1.15
0.17
1.0
1.0
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
24
214
1.12
0.17
1.2
1.1
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
81
855
0.95
0.17
2.8
1.9
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
15
129
1.16
0.17
1.0
1.1
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
69
0.72
0.17
1.0
1.1
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
794
7836
1.02
0.16
2.8
2.7
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
70
661
1.06
0.16
1.7
2.0
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
43
463
0.93
0.16
2.8
3.9
mg/l
37.5
23.9
0.73
22
290
(3028433) Virus identified in Specimen by Culture
8
72
1.11
0.16
1.1
1.3
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
32
349
0.92
0.15
1.1
1.1
u/ml
3.9
5.3
0.39
19
173
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
15
130
1.15
0.15
1.0
1.1
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
36
390
0.92
0.15
1.0
1.1
u/ml
1.6
1.5
0.07
18
154
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
10
83
1.21
0.15
1.4
1.7
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
243
2367
1.03
0.15
3.1
3.0
ug/l
0.7
0.8
0.35
171
1554
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
55
585
0.94
0.15
2.0
2.5
g/l
0.0
0.0
0.00
49
542
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
14
121
1.16
0.15
1.3
1.1
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
74
779
0.95
0.15
2.3
1.8
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
11
93
1.18
0.14
1.1
1.7
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
70
665
1.05
0.14
1.7
1.9
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
11
128
0.86
0.13
1.0
1.2
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
22
199
1.11
0.13
4.8
4.0
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
25
228
1.10
0.13
2.3
2.4
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
9
108
0.83
0.13
1.1
2.4
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
52
491
1.06
0.13
2.8
2.5
ug/min
99.2
119.4
0.11
31
310
(3005988) Vibrio sp identified in Specimen by Organism specific culture
26
283
0.92
0.12
1.8
1.4
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
15
169
0.89
0.12
1.4
1.4
mmol/l
11.4
12.2
—
6
46
(21494434) Karyotype in Bone marrow
16
179
0.89
0.12
1.1
1.2
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
21
191
1.10
0.11
1.5
1.6
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
11
95
1.16
0.11
1.5
2.6
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
81
778
1.04
0.11
2.5
2.5
g/l
3.0
3.1
0.25
60
611
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
60
629
0.95
0.11
2.0
2.5
g/l
0.1
0.0
0.35
54
583
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
26
281
0.92
0.11
1.8
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
26
281
0.92
0.11
1.8
1.4
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
64
612
1.05
0.11
1.3
1.3
—
—
—
0
0
(3022313) Gas panel - Capillary blood
86
892
0.96
0.11
4.5
3.5
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
21
229
0.92
0.10
6.2
3.1
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
10
115
0.87
0.10
1.6
1.4
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
33
352
0.94
0.10
1.2
1.1
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
37
348
1.06
0.10
1.2
1.1
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
13
115
1.13
0.10
1.1
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
66
688
0.96
0.10
1.2
1.2
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
5
46
1.09
0.09
1.0
1.1
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
76
733
1.04
0.09
4.2
3.2
g/l
0.2
0.3
1.64
34
281
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
5
47
1.06
0.09
1.2
1.2
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
5
48
1.04
0.09
1.0
1.2
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
11
97
1.13
0.09
1.0
1.1
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
15
165
0.91
0.08
1.1
1.4
mmol/l
1.9
2.0
0.61
15
156
(4015189)
6
57
1.05
0.08
4.8
2.6
—
—
—
0
0
(4211845)
12
107
1.12
0.08
1.7
3.3
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
25
267
0.94
0.08
1.7
2.2
mg/l
42.5
24.7
—
8
72
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
68
704
0.96
0.08
2.8
2.6
g/l
0.8
0.9
0.06
57
625
(3020650) Glucose [Presence] in Urine
5
61
0.82
0.08
1.0
1.6
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
5
62
0.81
0.08
1.0
1.1
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
5
63
0.79
0.08
1.0
1.4
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
53
509
1.04
0.08
1.7
1.7
e6/l
15561.2
10973.3
0.40
42
371
(3037556) Urate [Mass/volume] in Serum or Plasma
7
64
1.09
0.08
1.7
1.2
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
10
88
1.14
0.08
1.8
1.3
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
10
88
1.14
0.08
1.8
1.3
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
499
5039
0.99
0.08
3.9
3.6
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
63
608
1.04
0.08
1.7
2.0
—
—
—
0
0
(44813793)
15
164
0.91
0.08
1.1
1.1
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
6
72
0.83
0.07
1.0
1.5
ug/l
7.2
9.0
—
6
72
(3036071) Salmonella sp Ab [Titer] in Serum
6
75
0.80
0.07
1.0
1.1
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
396
3918
1.01
0.07
1.3
1.3
u/ml
15.5
10.9
0.52
151
1546
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
35
333
1.05
0.07
1.1
1.1
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
30
284
1.06
0.07
1.7
1.4
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
7
81
0.86
0.07
1.3
2.4
—
—
—
0
0
(3036489) Thrombin time
83
808
1.03
0.07
2.6
2.0
s
21.4
21.4
0.00
72
706
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
21
224
0.94
0.06
3.0
1.6
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
33
346
0.95
0.06
1.6
1.4
u/l
32.4
29.5
0.16
27
284
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
57
589
0.97
0.06
1.2
1.1
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
28
295
0.95
0.06
2.2
2.6
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
18
193
0.93
0.06
1.0
1.1
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
14
152
0.92
0.06
1.5
1.3
—
1.5
—
0
7
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
37
355
1.04
0.06
1.9
1.6
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
167
1695
0.98
0.05
2.0
2.3
ug/l
6.2
6.7
0.13
143
1499
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
406
4094
0.99
0.05
1.3
1.3
iu/ml
35.5
33.7
0.07
130
1308
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
10
90
1.11
0.05
1.0
1.2
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
43
444
0.97
0.04
2.2
2.2
nmol/l
0.9
0.8
0.40
32
370
(3024522) Salmonella sp identified in Specimen by Organism specific culture
30
288
1.04
0.04
1.7
1.4
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
53
516
1.03
0.04
1.8
2.0
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
11
101
1.09
0.04
1.1
1.0
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
18
170
1.06
0.04
2.1
2.1
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
17
180
0.94
0.04
1.4
1.5
g/l
1.0
1.0
0.15
17
180
(3029634) Reagin Ab [Titer] in Serum by VDRL
30
289
1.04
0.04
1.6
1.8
—
4.4
—
0
5
(3020874) Milk IgE Ab [Units/volume] in Serum
13
121
1.07
0.03
1.0
1.0
u/ml
0.4
0.9
—
7
43
(3027456) Digoxin [Moles/volume] in Serum or Plasma
40
389
1.03
0.03
3.3
3.1
nmol/l
0.8
0.8
0.08
34
297
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
56
572
0.98
0.03
1.4
1.4
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
41
421
0.97
0.03
1.7
3.1
umol/l
25.7
35.1
4.17
35
362
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
10
92
1.09
0.03
1.2
1.1
miu/ml
1950.3
1680.0
—
10
92
(3019832) Treponema pallidum Ab [Presence] in Serum
177
1754
1.01
0.03
1.6
1.6
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
33
320
1.03
0.03
1.2
1.2
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
11
102
1.08
0.03
1.8
1.6
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
11
102
1.08
0.03
1.8
1.6
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
22
211
1.04
0.03
1.0
1.1
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
26
251
1.04
0.02
1.2
1.1
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
14
132
1.06
0.02
1.1
1.1
u/l
1.1
1.1
—
8
73
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
68
669
1.02
0.02
1.4
1.3
miu/ml
221.1
222.0
0.01
36
317
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
19
198
0.96
0.02
2.8
2.6
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
69
700
0.99
0.02
1.2
1.2
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
34
332
1.02
0.01
1.2
1.1
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
14
147
0.95
0.01
1.1
1.2
—
—
—
0
0
(4024509)
22
213
1.03
0.01
1.7
1.6
—
—
—
0
0
(3019977) pH of Arterial blood
11
104
1.06
0.01
1.5
3.1
ph
7.4
7.4
—
5
32
(3004775) Volume in Urine collected for unspecified duration
18
174
1.03
0.00
2.1
2.3
ml
606.4
640.9
0.10
13
123
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
18
174
1.03
0.00
1.8
1.1
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
155
1544
1.00
0.00
1.4
1.4
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
306
3054
1.00
0.00
1.7
1.6
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
12
125
0.96
0.00
1.7
1.5
ug/l
7.0
7.4
0.09
12
105
(4027681)
14
135
1.04
0.00
1.4
1.2
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
12
121
0.99
0.00
1.3
1.2
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
15
149
1.01
0.00
1.1
1.1
—
—
—
0
0
(44806118)
25
249
1.00
0.00
1.6
1.4
—
—
—
0
0
(44790049)
25
249
1.00
0.00
1.6
1.4
—
—
—
0
0
(44790047)
25
249
1.00
0.00
1.6
1.4
—
—
—
0
0
(44790048)
25
249
1.00
0.00
1.6
1.4
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
63
625
1.01
0.00
1.2
1.3
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
12
124
0.97
0.00
1.3
1.7
mmol/l
9.4
8.0
—
6
76
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
263
2631
1.00
0.00
7.7
6.6
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
31
314
0.99
0.00
1.0
1.1
u/ml
0.1
2.4
—
7
75
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
10
98
1.02
0.00
1.8
2.5
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
19
188
1.01
0.00
4.4
3.1
mg/l
48.9
34.5
0.18
14
137
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
24
242
0.99
0.00
2.8
1.6
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
42
418
1.00
0.00
3.1
3.4
u/ml
587.6
1002.0
0.21
37
389
(1761482) Bacteria [#/volume] in Urine by Culture
50
498
1.00
0.00
3.8
4.3
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
69
692
1.00
0.00
1.2
1.2
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
10
97
1.03
0.00
1.7
3.4
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
24
243
0.99
0.00
1.4
1.7
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
8
84
0.95
0.00
1.1
1.3
—
—
—
0
0
(3026692) Albumin [Mass/volume] in Peritoneal fluid
6
59
1.02
0.00
1.5
1.5
g/l
13.7
14.1
—
6
44
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
5
51
0.98
0.00
2.6
1.2
—
—
—
0
0
(3029612) Listeria sp Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3045462) Protein/Creatinine [Ratio] in Urine
0
9
0.00
0.00
0.0
3.4
—
14.1
—
0
9
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007463) Buprenorphine [Presence] in Urine
0
8
0.00
0.00
0.0
2.6
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine
0
6
0.00
0.00
0.0
1.0
—
330.8
—
0
6
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3046682) IgA [Presence] in Skin by Immunofluorescence
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
6
67
0.90
0.00
1.5
1.8
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
7
75
0.93
0.00
1.4
1.1
—
—
—
0
0
(3027696) Helicobacter pylori Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.2
—
1308.0
—
0
5
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
9
96
0.94
0.00
5.0
1.8
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.8
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
6
67
0.90
0.00
3.5
1.9
—
—
—
0
0
(3034614) HLA Ag [Interpretation]
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
9
95
0.95
0.00
5.0
1.8
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
73
0.96
0.00
1.0
1.2
—
—
—
0
0
(3042301) Urate [Moles/volume] in Synovial fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038385) Creatinine [Moles/volume] in Peritoneal fluid
0
6
0.00
0.00
0.0
1.3
—
171.0
—
0
6
(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018738) Hemoglobin F/Hemoglobin.total in Blood
0
5
0.00
0.00
0.0
3.2
—
—
—
0
0
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
0
9
0.00
0.00
0.0
10.6
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
10
100
1.00
0.00
2.7
2.9
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
6
60
1.00
0.00
1.2
2.9
—
—
—
0
0
(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
9
95
0.95
0.00
5.0
1.8
—
—
—
0
0
(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool
0
9
0.00
0.00
0.0
1.3
—
192.6
—
0
9
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(3008640) Bordetella pertussis IgG Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011325) HIV 1+2 Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
12
120
1.00
0.00
1.2
1.2
—
—
—
0
0
(3033086) Enterovirus NOS Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
6
60
1.00
0.00
1.2
2.9
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_THYROID_GLAND – Malignant neoplasm of thyroid gland
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).